![Medical News Asia | Powered by ['mediPr]](https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png)
SARS-CoV-2 virus is the causative agent of Coronavirus Disease 2019 (COVID-19) and has infected many over the past two-and-a-half years, including healthy people and those with underlying co-morbidities such as the immunocompromised. Following the administration of COVID-19 vaccines from late 2020 onwards, severe and critical COVID-19 outcomes decreased by over 60%.
The gut microbiome is known to interact with infection and immunity, such as immune response after BCG vaccine and COVID-19 disease prognosis. Investigators are thus interested to learn whether certain gut microbiome composition can be prognostic indicators for adverse event occurrence and vaccine efficacy.
Disruption of standard patient care due to the COVID-19 pandemic has been long postulated, and is now supported by a study reported in the Journal of the American College of Cardiology reporting delays in the delivery of essential diagnostic services, particularly for cardiovascular conditions, affecting health outcomes.
While vaccines are starting to become available for the prevention of SARS-Cov-2 infection, it is anticipated that the Coronavirus 2019 (COVID-19) pandemic will continue for at least the next year.
我最近在YouTube頻道上看到這條在2020年12月17日發佈的視頻，聲稱說明有關COVID-19疫苗的功效和風險。該視頻的內容非常不準確且具有誤導性。 令我震驚的是，該視頻已吸引了超過三十萬觀看者，其中有幾位評論者表示同意偽科學。
While SARS-CoV2 has been previously reported to exist in lung tissue in a 78-year-old patient who died of unexpected cardiac arrest when ready for discharge after COVID-19 hospitalisation, recently the first evidence of SARS-CoV2 infection in heart muscle cells has been reported in a case from Brazil and which is supported by evidence from other reports.
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/2019-nCoV) in late 2019 has led to a global pandemic.
Dr Siddharth綜合了21個病例報告，並分析了目前1689名Covid-19肺炎患者的臨床特徵，以及2198名患者的人口統計學數據。
Dr Siddharth analysed the clinical characteristics of 1,689 #COVID19 patients from 21 publications, and the demographics of 2,198 2019nCoV patients.
